Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project.

Autor: Mathian É; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; Department of Mathematics and Informatics, Ecole Centrale de Lyon, Lyon, France., Drouet Y; UMR CNRS 5558 LBBE, Claude Bernard Lyon 1 University, Villeurbanne, France; Prevention & Public Health Department, Centre Léon Bérard, Lyon, France., Sexton-Oates A; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Papotti MG; Department of Oncology, University of Turin, Turin, Italy., Pelosi G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Vignaud JM; Department of Biopathology, Institut De Cancérologie de Lorraine (CHRU-ICL), Vandoeuvre-lès-Nancy, France; University Hospital of Nancy (CHRU), Nancy, France., Brcic L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Mansuet-Lupo A; Department of Pathology, Hôpital Cochin, AP-HP, Université de Paris, Paris, France., Damiola F; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Altun C; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Berthet JP; Department of Thoracic Surgery, FHU OncoAge, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Fournier CB; Caen Lower Normandy Tumour Bank, Centre François Baclesse, Caen, France., Brustugun OT; Section of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Centonze G; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chalabreysse L; Hospices Civils de Lyon, GHE, Institut de Pathologie Est, Bron, France., de Montpréville VT; Department of Pathology, Hôpital Marie-Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, France., di Micco CM; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Fadel E; Department of Pathology, Hôpital Marie-Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, France; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Université Paris-Saclay, Le Plessis-Robinson, France., Gadot N; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Graziano P; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Hofman P; FHU OncoAge, Biobank BB-0033-0025, Laboratory of Clinical and Experimental Pathology, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Hofman V; FHU OncoAge, Biobank BB-0033-0025, Laboratory of Clinical and Experimental Pathology, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Lacomme S; University Hospital of Nancy (CHRU), Nancy, France., Lund-Iversen M; Department of Pathology, Oslo University Hospital, Oslo, Norway., Mangiante L; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; School of Medicine, Stanford University, Stanford, USA., Milione M; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Muscarella LA; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Perrin C; Hospices Civils de Lyon, GHE, Institut de Pathologie Est, Bron, France., Planchard G; Pathology Department, Caen University Hospital, Normandy University, Caen, France., Popper H; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Rousseau N; Caen Lower Normandy Tumour Bank, Centre François Baclesse, Caen, France., Roz L; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Sabella G; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tabone-Eglinger S; Biological Resource Center, Centre Léon Bérard, Lyon, France., Voegele C; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Volante M; Department of Oncology, University of Turin, Turin, Italy., Walter T; Service d'Oncologie Médicale, Groupement Hospitalier Centre, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France., Dingemans AM; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Moonen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, Netherlands., Speel EJ; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, Netherlands., Derks J; Department of Pulmonary Diseases, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Girard N; Institut Curie, Versailles, France., Chen L; Department of Mathematics and Informatics, Ecole Centrale de Lyon, Lyon, France; Institut Universitaire de France (IUF), Paris, France., Alcala N; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Fernandez-Cuesta L; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Electronic address: fernandezcuestal@iarc.who.int., Lantuejoul S; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Foll M; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Publikováno v: ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103591. Date of Electronic Publication: 2024 Jun 14.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Autor: Jacquemier J; Institut Paoli Calmettes, biopathology department, 232 Bd Ste Marguerite, 13009, Marseille, France. jacquemierj@ipc.unicancer.fr, Spyratos F, Esterni B, Mozziconacci MJ, Antoine M, Arnould L, Lizard S, Bertheau P, Lehmann-Che J, Fournier CB, Krieger S, Bibeau F, Lamy PJ, Chenard MP, Legrain M, Guinebretière JM, Loussouarn D, Macgrogan G, Hostein I, Mathieu MC, Lacroix L, Valent A, Robin YM, Revillion F, Triki ML, Seaume A, Salomon AV, de Cremoux P, Portefaix G, Xerri L, Vacher S, Bièche I, Penault-Llorca F

Publikováno v: BMC cancer [BMC Cancer] 2013 Jul 22; Vol. 13, pp. 351. Date of Electronic Publication: 2013 Jul 22.